What is Merit Medical Systems's market cap?

Merit Medical Systems (MMSI) has a market capitalization of $4.5B and trades on NASDAQ.

What is Merit Medical Systems's revenue and profitability?

Merit Medical Systems generated $1.5B in trailing twelve-month revenue with net income of $139.3M, representing a net margin of 9.0%. Gross margin stands at 48.7%, with free cash flow of $220.8M. These figures are based on the Q1 2026 filing.

Who are Merit Medical Systems's competitors?

Merit Medical Systems's key competitors include Boston Scientific Corporation, Stryker Corporation, Medtronic plc, and others. These companies compete in similar markets and product categories.

Who does Merit Medical Systems partner with?

Merit Medical Systems's notable partners include Gallup, University of Utah.

What subsidiaries does Merit Medical Systems have?

Merit Medical Systems's subsidiaries include Merit Sensor Systems, Inc., Merit Medical Endotek.

Where is Merit Medical Systems headquartered?

Merit Medical Systems is headquartered in United States of America and employs approximately 6,950 people. It has been publicly traded since 1990.

Merit Medical Systems

MMSI

Merit Medical Systems is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures.

Market cap

$4.54B-7.4%

Revenue$1.5B+11.1%

Net income$139.3M+14.0%

Free cash flow$220.8M+22.2%

EPS (diluted)$2.32+13.7%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 30, 2026

Revenue$381.9MBeat by $4.3M EPS$0.94Beat by $0.10

Read the full report

Next report

Jul 30, 2026 (Tomorrow)

Revenue estimate$405.2M

EPS estimate$0.96

Financials

Q1 2026

Income statement

See full

Revenue$381.9M+7.5%

Gross profit$184.8M+7.4%

Operating income$44.2M+7.6%

Net income$41.0M+36.0%

EPS (diluted)$0.68+38.8%

Balance sheet

See full

Cash & equivalents$488.1M+23.4%

Total debt$821.6M+0.5%

Total equity$1.6B+13.9%

Total assets$2.7B+10.2%

Cash flow

See full

Operating cash flow$40.7M+0.3%

CapEx$16.0M-24.0%

Free cash flow$24.7M+26.5%

Valuation & ratios

Valuation

See full

Market cap$4.54B-7.4%

Enterprise value$4.87B-10.9%

P/E32.6×-9.3×

P/S2.9×-0.5×

Profitability

See full

Gross margin48.7%+0.9pp

Operating margin12.2%+0.6pp

Net margin9%+0.2pp

FCF margin14.3%+1.3pp

Returns & leverage

See full

Return on equity9.1%0.0pp

Debt / equity0.5×-0.1×

Current ratio5.1×+0.2×

Segments

By product

See full

Foundational$255.5M—

Therapeutic$126.4M—

By segment

See full

Single Reportable$381.9M—

Competitors

By market cap

Johnson & Johnson$640.91B+60.1%

Abbott$182.00B-17.2%

Stryker$129.09B-15.7%

Medtronic$107.81B-8.5%

Boston Scientific$67.6B-56.8%

Becton, Dickinson and Company$43.8B-16.5%

TFX

Teleflex$5.8B+13.6%

Merit Medical Systems$4.5B-9.1%

By revenue growth

TFX

Teleflex+25.0%

Boston Scientific+13.5%

Merit Medical Systems+11.1%

Stryker+8.8%

Medtronic+8.4%

Abbott+8.1%

Johnson & Johnson+8.1%

Becton, Dickinson and Company+6.4%

By net margin

Johnson & Johnson21.48%-3.5pp

Boston Scientific17.48%+4.0pp

Stryker13.21%+0.9pp

Medtronic13.2%-0.7pp

Abbott11.65%-20.8pp

Merit Medical Systems9.03%+0.2pp

Becton, Dickinson and Company5.33%-2.1pp

TFX

Teleflex-47.43%-56.2pp

Profile

Merit Medical Systems is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures. The company specializes in cardiology, radiology, oncology, critical care, and endoscopy, providing a diverse range of products that facilitate minimally invasive diagnosis and treatment. Its value proposition centers on being a customer-focused provider of high-quality medical tools and custom procedural solutions like kits and trays.

Competitive position

A leading global provider of digital and analog inflation technology, control syringes, and wire-free tumor localization systems.

GeographiesUnited States, China, Europe, Middle East, Africa, Asia, Oceania, Americas

Customer segmentsHospitals, Outpatient access centers, Integrated healthcare networks, Medical device manufacturers

Business modelManufacturing, Direct Sales, B2B, OEM

SuppliersPlastic injection molding suppliers, Tooling manufacturers, Raw material providers, Contract manufacturers

CustomersHospitals, Physicians, Custom procedure tray manufacturers, Medical device OEMs

CountryUnited States of America

Listed1990

Employees7.0K

CEOMartha Goldberg Aronson

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websitemerit.com

FilingsSEC EDGAR

Ask your AI about Merit Medical Systems.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Merit Medical Systems's market cap?: Merit Medical Systems (MMSI) has a market capitalization of $4.5B and trades on NASDAQ.
What is Merit Medical Systems's revenue and profitability?: Merit Medical Systems generated $1.5B in trailing twelve-month revenue with net income of $139.3M, representing a net margin of 9.0%. Gross margin stands at 48.7%, with free cash flow of $220.8M. These figures are based on the Q1 2026 filing.
Who are Merit Medical Systems's competitors?: Merit Medical Systems's key competitors include Boston Scientific Corporation, Stryker Corporation, Medtronic plc, and others. These companies compete in similar markets and product categories.
Who does Merit Medical Systems partner with?: Merit Medical Systems's notable partners include Gallup, University of Utah.
What subsidiaries does Merit Medical Systems have?: Merit Medical Systems's subsidiaries include Merit Sensor Systems, Inc., Merit Medical Endotek.
Where is Merit Medical Systems headquartered?: Merit Medical Systems is headquartered in United States of America and employs approximately 6,950 people. It has been publicly traded since 1990.